YIPF2

YIPF2 is a multi-pass transmembrane protein of the medial-/trans-Golgi network that functions as a Rab GDI-displacement factor (GDF) and cargo trafficking regulator, linking Golgi membrane dynamics to endocytic recycling, glycosylation, and genome integrity. YIPF2 recruits and activates Rab5 and Rab22a on endomembranes to control endocytic recycling of cargo proteins such as CD147 and TNFRSF10B, and physically interacts with RAB8 to inhibit RAB8-mediated internalization of TNFRSF10B, thereby sustaining its surface levels and enhancing TRAIL-dependent apoptosis (PMID:31189879, PMID:32303681). It forms a stable complex with YIPF6 and is required for Golgi reassembly after brefeldin A treatment and for intracellular glycan synthesis (PMID:28286305). YIPF2 depletion also impairs homologous recombination DNA repair and triggers cellular senescence, revealing an unexpected role for this Golgi-resident protein in maintaining genome integrity (PMID:39238039).

1. 2016 Medium

   Establishing where YIPF2 resides and how it is oriented: topology and localization experiments placed YIPF2 at the trans-Golgi with five transmembrane domains and a cytosol-facing N-terminus, and showed that its depletion alters Golgi morphology, implicating it in Golgi structure maintenance.

   Evidence Immunofluorescence, RNA interference, and membrane topology assays in cultured cells

   PMID:27999994

   Open questions at the time

   • Topology determined by a single lab; independent confirmation with protease protection or glycosylation mapping not reported
   • Mechanism by which YIPF2 depletion disrupts Golgi morphology not defined
   • No interacting partners identified at this stage
2. 2017 High

   Demonstrating that YIPF2 forms a functional complex with YIPF6 and is required for Golgi reassembly and glycan biosynthesis resolved the question of how Yip-family proteins cooperate at the Golgi and linked YIPF2 to post-mitotic Golgi reformation.

   Evidence Reciprocal immunoprecipitation for YIPF2–YIPF6 complex, brefeldin A washout Golgi reassembly kinetics, glycan detection assays, and RNAi in HT-29 cells

   PMID:28286305

   Open questions at the time

   • Stoichiometry and direct versus indirect nature of the YIPF2–YIPF6 interaction not resolved
   • Whether glycan reduction is a direct biosynthetic defect or secondary to Golgi disorganization is unclear
3. 2019 High

   Identifying YIPF2 as a Rab-GDF that activates Rab5 and Rab22a answered the long-standing question of how Rab GTPases are recruited to ER-Golgi membranes, and connected this activity to CD147 endocytic recycling and glycosylation in hepatocellular carcinoma cells.

   Evidence MAPPIT interaction screen, GST-RBD pulldown for activated Rab, confocal colocalization, biotin-chase recycling assays, gelatin zymography in HCC cells

   PMID:31189879

   Open questions at the time

   • Structural basis of GDF activity not determined
   • Whether YIPF2 acts on additional Rab family members beyond Rab5 and Rab22a is untested
   • In vivo relevance of CD147 recycling regulation not shown
4. 2020 Medium

   Showing that YIPF2 physically interacts with TNFRSF10B and RAB8 and opposes RAB8-mediated receptor internalization established YIPF2 as a regulator of death receptor surface availability and chemotherapy-induced apoptosis.

   Evidence Co-immunoprecipitation, siRNA knockdown, flow cytometry for surface TNFRSF10B, and apoptosis assays in NSCLC cells

   PMID:32303681

   Open questions at the time

   • Single-lab co-IP; reciprocal endogenous validation limited
   • Whether YIPF2 directly competes with RAB8 for TNFRSF10B binding or acts indirectly is unresolved
   • Generalizability of this mechanism to other death receptors not tested
5. 2024 Medium

   Discovery that YIPF2 depletion impairs homologous recombination DNA repair and induces senescence, while its overexpression rescues DNA damage, unexpectedly extended YIPF2 function beyond membrane trafficking to genome maintenance.

   Evidence Whole-genome RNAi screen, HR repair reporter assays, DNA damage response markers, senescence assays, and overexpression rescue experiments

   PMID:39238039

   Open questions at the time

   • Mechanistic link between Golgi-resident YIPF2 and nuclear HR repair machinery is unknown
   • Whether YIPF2 translocates to the nucleus or acts indirectly through signaling has not been tested
   • Single-lab finding not yet independently replicated
6. 2024 Medium

   Demonstration that YIPF2 inhibition increases CD147 surface levels in oligodendrocytes and rescues demyelination in a diabetic encephalopathy model extended the CD147-trafficking function to a disease-relevant neural context.

   Evidence Western blot, co-immunoprecipitation, proteomics, and in vivo YIPF2 inhibition in diabetic encephalopathy model mice

   PMID:39078594

   Open questions at the time

   • Pharmacological tool for YIPF2 inhibition not well characterized; off-target effects possible
   • Direction of YIPF2 effect on CD147 surface levels appears opposite to HCC findings, mechanistic reconciliation absent
   • Long-term consequences of YIPF2 inhibition in vivo not assessed

• The structural basis of YIPF2's Rab-GDF activity and the mechanism linking this Golgi-resident protein to nuclear homologous recombination remain major open questions.
• No crystal or cryo-EM structure of YIPF2 or YIPF2–Rab complex exists
• Whether YIPF2 has a nuclear pool or acts on HR indirectly via signaling is unknown
• Context-dependent directionality of YIPF2 effects on CD147 trafficking (retention vs. recycling) has not been mechanistically explained